Appeal No. 2001-1051 Page 5 Application No. 08/185,079 Tidwell III at Col. 11, ll. 43-45 teaches that “[t]he results in Table 5 also reveal that the inhibitor produced a slight but consistent decrease in the yield of P-3 virus.” That statement, however, relates to a single compound and a single virus, and thus does not render the prior express teaching of Tidwell moot. In addition, the decrease is only slight, thus the above statement, when read with the statement that the suppressive effect of the compound is virus specific, would not motivate one of ordinary skill to use the compounds on another, completely different virus, i.e., a retrovirus. Vonderfecht does not remedy the deficiencies of the Tidwell references. Vonderfecht teaches that one compound, BABIM, which falls within the claimed genus of compounds, is the most potent synthetic, reversible inhibitor of trypsin yet identified. See Vonderfecht, page 2011, col. 2. The reference also teaches that BABIM restricts the intestinal replication of the murine of rotavirus when the compound and the virus were administered simultaneously to suckling mice. See Vonderfecht, abstract. Finally, as relied upon by the examiner, Vonderfecht also teaches: In this instance, it was shown that BABIM delays viral penetration into cells by its antiprotease action but does not interfere with viral RNA replication. Protease inhibitors such as the ones described in this report represent a new class of viral agents that functions at the level of protein interactions and would not be expected to have such potential for long-term untoward effects on mammalian nucleic acids. In addition, many pathogenic viruses, including myxoviruses, paramyxoviruses, retroviruses, coronaviruses, and poxviruses, require viral or host proteases for productive infection. Thus, chemotherapeutic agents which possess protease inhibitory activity may have a broad range of antiviral activity. The availability of antiviral agents capable of inhibiting a wide range of pathogenic viruses without interfering with host nucleic acid replication mayPage: Previous 1 2 3 4 5 6 7 8 NextLast modified: November 3, 2007